← Leaderboards
Chester V Oddis
University Of Pittsburgh At Pittsburgh
$722,057
Attributed
$1,320,880
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $321.1K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,320,880 · 3
By mechanism
R01$1,197,647 · 1
M01$123,233 · 2
Top collaborators
- Marc C. Levesque4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dana P Ascherman$3,212,537
- Benoit H Mulsant$5,603,424
- Charles F Reynolds$34,949,629
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAffectChemokineAdultAutoimmune DiseasesAutoimmune ProcessBaseAntigen-Presenting CellsAutoantibodiesBloodB-LymphocytesCell CountCell PhysiologyCessation Of LifeAdult DermatomyositisChildhoodB-Cell DevelopmentClinical DataBiologicalCytokineCohortControlled Clinical TrialsControlled StudyData Set
Grant awards (7)
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$282,301
R01 · FY2013 · AR · contact PI
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$297,142
R01 · FY2012 · AR · contact PI
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$297,126
R01 · FY2011 · AR · contact PI
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$321,078
R01 · FY2010 · AR · contact PI
RADIOGRAPHIC DET POTENTIAL DISEASE MODIF OF GLUCOSAMINE/CHONDROITIN/COMBO$22,651
M01 · FY2005 · RR
STUDY OF EFFICACY OF GLUCOSAMINE/CHONDROITIN SULFATE IN KNEE OSTEOARTHRITIS$3,664
M01 · FY2005 · RR
Glucosamine/Chondroitin Sulfate in Knee Osteoarthritis$96,918
M01 · FY2004 · RR